Jonathan P. Orme

815 citations
13 papers · 195 · h-index 5

Impact in

Papers in

Co-authors
Darren A.E. Cross (7 shared papers)Matthew J. Martin (5 shared papers)Nicolas Floc’h (6 shared papers)Darren McKerrecher (5 shared papers)M. Raymond V. Finlay (5 shared papers)Richard A. Ward (6 shared papers)Daniel O’Neill (5 shared papers)Jonathan W. Riess (1 shared paper)
Journals
SLAS DISCOVERY (3 papers)Molecular Cancer Therapeutics (2 papers)ACS Medicinal Chemistry Letters (2 papers)Cancer Research (2 papers)Scientific Reports (1 paper)
Partner nations
United KingdomUnited StatesGermany

In The Last Decade

Jonathan P. Orme

13 papers receiving 189 citations

Peers

Jonathan P. Orme
Comparison fields: 5 of 45
  • Pulmonary and Respiratory Medicine 111
  • Oncology 77
  • Cancer Research 23
  • Molecular Biology 95
  • Aging 2
Replace Silvia Buriolla with:
Silvia Buriolla Italy
Marni Brisson Tierno United States
Deborah Ayeni United States
Cyrus L. Harmon United States
Antonia Del Giudice Italy
Nancy E. Sealover United States
Hannah L. Tumbrink Germany
Daria Allina Russia
Andrea Kazumi Shimada Brazil
Amir Noeparast Belgium
Jonathan P. Orme relative to Silvia Buriolla Italy Silvia Buriolla's profile →
Citations per field
00.5×5×10×15×22×
Silvia Buriolla · 1×
Citations per year

Countries citing papers authored by Jonathan P. Orme

Since Specialization
Citations

This map shows the geographic impact of Jonathan P. Orme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan P. Orme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan P. Orme more than expected).

Fields of papers citing papers by Jonathan P. Orme

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan P. Orme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan P. Orme. The network helps show where Jonathan P. Orme may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan P. Orme, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan P. Orme Line = papers co-authored together Jonathan P. Orme links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1
Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions
Molecular Cancer Therapeutics ·Nicolas Floc’h, Matthew J. Martin, Jonathan W. Riess, Jonathan P. Orme, Anna D. Staniszewska, Ludovic Ménard, Maria Emanuela Cuomo, Daniel O’Neill, Richard A. Ward, M. Raymond V. Finlay, Darren McKerrecher, Mingshan Cheng, Daniel P. Vang, Rebekah A. Burich, James Keck, David R. Gandara, Philip C. Mack, Darren A.E. Cross
201887
2
Osimertinib, an Irreversible Next-Generation EGFR Tyrosine Kinase Inhibitor, Exerts Antitumor Activity in Various Preclinical NSCLC Models Harboring the Uncommon EGFR Mutations G719X or L861Q or S768I
Molecular Cancer Therapeutics ·Nicolas Floc’h, Sangbin Lim, Sue Bickerton, Afshan Ahmed, Jonathan P. Orme, Jelena Urosevic, Matthew J. Martin, Darren A.E. Cross, Byoung Chul Cho, Paul D. Smith
202038
3
Positioning High-Throughput CETSA in Early Drug Discovery through Screening against B-Raf and PARP1
SLAS DISCOVERY ·Joseph Shaw, Ian L. Dale, Paul Hemsley, Lindsey Leach, Nancy Dekki, Jonathan P. Orme, Verity Talbot, A.J. Narvaez, Michał Biśta, Daniel Martinez Molina, Michael Dabrowski, Martin J. Main, Davide Gianni
201837
4
Abstract 4451: Evaluation of the therapeutic potential of phosphine oxide pyrazole inhibitors in tumors harboring EGFR C797S mutation
Cancer Research ·Nicolas Floc’h, M. Raymond V. Finlay, Ambra Bianco, Sue Bickerton, Nicola Colclough, Darren A.E. Cross, Emanuela M. Cuomo, Carine Guérot, David Hargreaves, Matthew J. Martin, Darren McKerrecher, Daniel O’Neill, Jonathan P. Orme, Amar Rahi, Paul Smith, Richard A. Ward
20199
5
Utilization of Structure-Based Design to Identify Novel, Irreversible Inhibitors of EGFR Harboring the T790M Mutation
ACS Medicinal Chemistry Letters ·Edward J. Hennessy, Claudio Chuaqui, Susan Ashton, Nicola Colclough, Darren A.E. Cross, J.E. Debreczeni, Cath Eberlein, Lakshmaiah Gingipalli, Teresa Klinowska, Jonathan P. Orme, Sha Li, Xiaoyun Wu
20167
6
Cellular Assay Optimization: Part I: The Use of Large-Scale Transiently Transfected Cryobanks and Introduction of a c-Myc Tag to Design a Standardized ELISA Process
SLAS DISCOVERY ·Marie A. Macmillan, David I. Fisher, Karen Roberts, Jonathan P. Orme
20114
7
An automated cell line authentication method for AstraZeneca global cell bank using deep neural networks on brightfield images
Scientific Reports ·Lei Tong, Adam Corrigan, Navin Rathna Kumar, Kerry Hallbrook, Jonathan P. Orme, Yinhai Wang, Huiyu Zhou
20224
8
Cellular Assay Optimization: Part II: The Use of a Simple Integrated Robotic Work Cell to Allow the Multiplexed Batching of Cellular Assays
SLAS DISCOVERY ·Marie A. Macmillan, Jonathan P. Orme, Karen Roberts
20113
9
CLANet: A comprehensive framework for cross-batch cell line identification using brightfield images
Medical Image Analysis ·Lei Tong, Adam Corrigan, Navin Rathna Kumar, Kerry Hallbrook, Jonathan P. Orme, Yinhai Wang, Huiyu Zhou
20242
10
Abstract 4813: Comparative activity profiling of tyrosine kinase inhibitors (TKIs) against exon 20 insertions and the wild-type form of epidermal growth factor receptor (EGFR)
Cancer Research ·Richard A. Ward, Ambra Bianco, Nicola Colclough, Darren A.E. Cross, Emanuela M. Cuomo, M. Raymond V. Finlay, Martina Fitzek, Nicolas Floc’h, Sladjana Gagrica, Beverley Hammond, Matthew J. Martin, Darren McKerrecher, Daniel O’Neill, Jonathan P. Orme, Paul D. Smith, Anna D. Staniszewska, Jelena Urosevic, Nicky Whalley, James Yates
20191
11
Abstract 4451: Evaluation of the therapeutic potential of phosphine oxide pyrazole inhibitors in tumors harboring EGFR C797S mutation
Nicolas Floc’h, M. Raymond V. Finlay, Ambra Bianco, Sue Bickerton, Nicola Colclough, Darren A.E. Cross, Emanuela M. Cuomo, Carine Guérot, David Hargreaves, Matthew J. Martin, Darren McKerrecher, Daniel O’Neill, Jonathan P. Orme, Amar Rahi, Paul D. Smith, Richard A. Ward
20191
12
Osimertinib (AZD9291), an irreversible 3rd generation TKI, induces tumor growth inhibition in NSCLC pre-clinical models harboring the most prevalent EGFR Ex20Ins (in vitro and in vivo)
European Journal of Cancer ·Richard A. Ward, S. Ashton, A R Bianco, Nicola Colclough, Darren A.E. Cross, Emanuela M. Cuomo, M. Raymond V. Finlay, Nicolas Floc’h, Martina Fitzek, Michel Martin, Ludovic Ménard, Darren McKerrecher, Daniel O’Neill, Jonathan P. Orme, Verity Talbot, Anna D. Staniszewska, James Yates
20161
13
Vinylpyridine as a Tunable Covalent Warhead Targeting C797 in EGFR
ACS Medicinal Chemistry Letters ·Nils Pemberton, Nina Compagne, Argyrides Argyrou, Emma Evertsson, Anders Gunnarsson, Jason G. Kettle, Jonathan P. Orme, Richard A. Ward
20241

About Jonathan P. Orme

Jonathan P. Orme is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Biophysics and Biomedical Engineering, having authored 13 papers that have together received 195 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Innovative Microfluidic and Catalytic Techniques Innovation (3 papers), HER2/EGFR in Cancer Research (3 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Digital Imaging for Blood Diseases (2 papers), Cancer therapeutics and mechanisms (2 papers), Cell Image Analysis Techniques (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (111 citations), Oncology (77 citations), Cancer Research (23 citations), Molecular Biology (95 citations) and Aging (2 citations). Jonathan P. Orme has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Darren A.E. Cross, Matthew J. Martin, Nicolas Floc’h, Darren McKerrecher, M. Raymond V. Finlay, Richard A. Ward, Daniel O’Neill, Jonathan W. Riess, Maria Emanuela Cuomo and James Keck. Their work appears in journals such as SLAS DISCOVERY, Molecular Cancer Therapeutics, ACS Medicinal Chemistry Letters, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia BuriollaBreakdown of academic impact, for papers by Marni Brisson TiernoBreakdown of academic impact, for papers by Deborah AyeniBreakdown of academic impact, for papers by Cyrus L. HarmonBreakdown of academic impact, for papers by Antonia Del GiudiceBreakdown of academic impact, for papers by Nancy E. SealoverBreakdown of academic impact, for papers by Hannah L. TumbrinkBreakdown of academic impact, for papers by Daria AllinaBreakdown of academic impact, for papers by Andrea Kazumi ShimadaBreakdown of academic impact, for papers by Amir Noeparast